Indivior Pharmaceuticals INDV
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 35.88 | -98 | 102 | 7.80 | 1,201 | |
| 2025Q3 | 24.11 | -207 | 43 | 3.00 | 1,416 | |
| 2025Q2 | 14.74 | -257 | 18 | 1.27 | 1,452 | |
| 2025Q1 | 9.53 | -285 | 47 | 3.49 | 1,375 | |
| 2024Q4 | 12.43 | -337 | 59 | 4.24 | 1,316 | |
| 2024Q3 | 9.75 | -167 | 22 | 1.47 | 1,464 | |
| 2024Q2 | 16.12 | -121 | -97 | -6.49 | 1,535 | |
| 2024Q1 | 21.42 | 10 | 61 | 3.58 | 1,453 | |
| 2023Q4 | 15.27 | 0 | 54 | 2.84 | 1,954 | |
| 2023Q3 | 23.07 | -24 | -135 | -7.54 | 1,852 | |
| 2023Q2 | 23.80 | 117 | 41.27 | 39 | 2.24 | 1,731 |
| 2023Q1 | 72 | 71.54 | 44 | 2.50 | 1,755 | |
| 2022Q4 | 51 | -131.65 | -183 | -10.64 | 1,769 | |
| 2022Q3 | 227 | 17.94 | 41 | 2.42 | 1,671 | |
| 2022Q2 | 230 | 20.78 | 48 | 2.79 | 1,720 | |
| 2022Q1 | 232 | 41 | 1,724 | |||
| 2020Q4 | 82 | -148 | 1,531 |